Navigant Healthcare’s Charlie Cosovich explores the dynamics that are influencing partnership strategy among healthcare providers in the field of oncology care. Cancer’s prevalence makes it critical to all providers because of the impressions made on patients and their families during the course of cancer care. The best impression is made by a well-coordinated, patient-centered experience, and partnering across provider types can help deliver this promise. At the same time, substantial and persistent changes to standards of cancer care are driven by accelerating scientific understanding. Partnering can offer overview needed to stay abreast of changing standards. After decades on the increase, pressures are mounting that will reduce the number of distinct treatments per patient – fewer infusions, surgical procedures, radiation oncology treatments and office visits for any given patient during the acute phase of their care. Evidence suggests much care is unnecessary with rates of use that vary dramatically in different parts of the US and little Comparative Effectiveness Research to define the best care. Provider partnerships can help cover wider geographies and populations and thereby support major capital equipment investments needed to meet modern standards of care. Still, partnering among providers is fraught with challenges and under increasing scrutiny from regulators and efforts at payment reform will come slowly to the complex environment of oncology care. Charlie identifies issues and considerations involved in oncology-related partnerships, and shares how to prepare for and manage expectations around partnering discussions.
Clipping is a handy way to collect important slides you want to go back to later.